It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...

The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover ...

Medicare coverage would reduce out-of-pocket costs for AOMs – which can currently be as high as $1,000 a month - by as much ...

The Centers for Medicare and Medicaid Services proposed changes to reduce prescription drug costs for Medicare Advantage and ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.